Fundamentals To A Very Successful Future, page-112

This is important: It is the Australian Category B TGA approvals for medical cannabis perscriptions / these numbers are now growing and will soon be materal - MDC doesnt disclose market share other than to say they are a significant supplier - Sales for Q4 will be interesting but the momentum here is excellent 

If the insto selling (from emlbourne) has slowed as it appears, then there may well be a proper chane of a rally on any positive news on exposure to these growing numbers

As I have said, a regsiterd form drug is one outcome but will take time. In the inetrim legal MC markets such as Europe, Canada, some US states and now increasingly Australia are all areas MDC should be pursuing vigorously. All for the science but lets make the $$$$$ where we can today !!!!

Everyone has seen what happens when real revenues flow with EXL 

MDC should be similar story if it can focus on commercial opportunities under its nose